Although our validation recovered genes known to be associated with NFκB and prostate cancer (S8–S11 Tables) and the majority of our predictions were co-expressed in lethal prostate cancer (S6 and S7 Figs, S15 Table), we did not recover all known genes, e.g. WNT16 or TP53. This evidence concerns the gene NFKB1 and prostate cancer.